ParambirSinghDulaiMD

Inflammatory Bowel Disease

Physician

Dr. Dulai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
259 E Erie St
Ste 1600
Chicago, IL 60611
Phone+1 312-695-5620

Fax+1 312-695-2729

University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2017
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2010 - 2014
Dayanand Medical College Class of 2009

Hyperbaric Oxygen for Ulcerative Colitis Start of enrollment: 2013 Aug 01
Terminated
Phase 2, Phase 3
Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares Start of enrollment: 2017 Sep 07
Completed
Phase 2

PubMed

109 citations
Risks of Serious Infection or Lymphoma With Anti–Tumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease: A Systematic Review
Parambir S. Dulai, Kimberly D. Thompson, Heather B. Blunt, Marla Dubinsky, Corey A. Siegel
Clinical Gastroenterology and Hepatology. 2014-09-01
1207 citations
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.
Parambir S. Dulai, Siddharth Singh, Janki Patel, Meera Soni, Larry J. Prokop
Hepatology. 2017-03-31
116 citations
Systematic review with meta-analysis: faecal diversion for management of perianal Crohn's disease.
Siddharth Singh, Nik S. Ding, Kellie L. Mathis, Parambir S. Dulai, Ann M. Farrell
Alimentary Pharmacology & Therapeutics. 2015-10-01

Journal Articles

Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Leah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel Diseases
Waseem Ahmad, Daniel Bouland, Nghia H Nguyen, David T Pride, Siddharth Singh, Parambir S Dulai, William J Sandborn, Brigid S Boland, Digestive Diseases and Sciences
Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts
Parambir S Dulai, William J Sandborn, Brigid S Boland, Derek R Patel, Inflammatory Bowel Diseases
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Gursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
No Benefit of Concomitant 5-Aminosalicylates in Patients with Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data from Cli...
Siddharth Singh, Parambir S Dulai, William J Sandborn, Nature
Join now to see all

Understanding a Novel Mechanism of Action in Ulcerative ColitisOctober 21st, 2024
Oxygen Therapy Offers Promising Results in People with Crohn’s FistulasFebruary 1st, 2023
Digbi Health Launches Digbi Digestive™, the First Gut Microbiome and Genetic-Based Digital Care Program to Address IBS and Functional Digestive Disorders Affecting 70M AmericansJune 16th, 2021